Dietary Lactobacillus-Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy.
Kawanabe-Matsuda H, Takeda K, Nakamura M, Makino S, Karasaki T, Kakimi K, Nishimukai M, Ohno T, Omi J, Kano K, Uwamizu A, Yagita H, Boneca IG, Eberl G, Aoki J, Smyth MJ, Okumura K.
Kawanabe-Matsuda H, et al. Among authors: kakimi k.
Cancer Discov. 2022 May 2;12(5):1336-1355. doi: 10.1158/2159-8290.CD-21-0929.
Cancer Discov. 2022.
PMID: 35180303
Free PMC article.